Drug firm Marksans Pharma today said it has received certificate of good manufacturing practice (GMP) compliance from the Australian drugs and devices regulator for its Verna facility in Goa.
The company has received "Certificate of GMP Compliance of a Manufacturer" from Therapeutic Goods Administration (TGA), Department of Health, Australia for its manufacturing facility at Verna in Goa, Marksans Pharma said in a filing to BSE.
TGA is Australia's regulatory agency for medical drugs and devices.
Shares of Marksans Pharma were today trading at Rs 51.45 per scrip in the afternoon trade on BSE, down 1.44 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
